Stock listing

Hikma Pharmaceuticals Plc

Selected listing: HIK · BX · CHF · CH

Hikma Pharmaceuticals Plc (BX Swiss: HIK), Health Technology. Latest release Sep 24, 2026: Hikma appoints Rebecca Hall as CFO.

HIK:BXCHFCHUpdated October 2, 2026

Ticker: BX Swiss: HIK
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Generic
Exchange: BX Swiss
Currency: CHF

About Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc is a public company listed on the UK market under the ticker HIK. Hikma specializes in the development and manufacturing of generic and branded pharmaceuticals, serving healthcare needs globally.

Latest news from Hikma Pharmaceuticals Plc

Hikma appoints Rebecca Hall as CFO

September 24, 2026

Hikma R&D Investor Spotlight Series

September 22, 2026

Hikma advances its epinephrine nasal spray with multi-market regulatory filings

September 10, 2026

Hikma Pharmaceuticals : advances its epinephrine nasal spray with multi-market regulatory filings

September 9, 2026

Hikma Pharmaceuticals : advances climate progress with first solar energy agreement

August 11, 2026

All Hikma Pharmaceuticals Plc news →

Events

Replays

Hikma Pharmaceuticals PLC (HIK) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 04:30 AM ET
Watch
Hikma Pharmaceuticals PLC (HIK) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 04:30 AM ET
Watch
Hikma Pharmaceuticals PLC (HIK) Q2 2025 Earnings Call
Thu, Aug 07, 2025 · 07:00 AM ET
Watch

Research Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc company profile

View the public company page for Hikma Pharmaceuticals Plc on 6ix.

Hikma Pharmaceuticals Plc news

Read company news and market updates connected to Hikma Pharmaceuticals Plc.

Hikma Pharmaceuticals Plc investor events

Find investor webinars, events, and replay context for Hikma Pharmaceuticals Plc.